Navigation Links
SynteractHCR Senior Director of Clinical Operations Mary Clegg Named One of the PharmaVOICE 100 Most Inspiring People in Life Sciences
Date:8/1/2013

SAN DIEGO, Aug. 1, 2013 /PRNewswire/ -- SynteractHCR, a leading full-service global contract research organization (CRO), is pleased to announce Mary Clegg, senior director of clinical operations, as one of the recipients of the 2013 PharmaVOICE 100 Most Inspiring People in the Life Sciences industry. PharmaVOICE magazine releases this top 100 list annually and identifies industry thought leaders and innovators that have the biggest impact on the entire field of life sciences. Clegg is the third executive from SynteractHCR that has been recognized in the past five years.

(Logo:  http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

Clegg was nominated by her peers because of her strong organizational aptitude and ability to lead and motivate with a "tirelessly positive" attitude. Her top quality management skills have been developed based on more than 20 years of experience in the industry. A registered nurse with extensive clinical trial experience in multiple therapeutic areas, Clegg has a proven ability to manage multiple projects and sites in accordance with FDA regulations. Clegg was named to the Top 100 because of her ability to influence others while being a thought leader in the industry.

"I am very pleased to see Mary recognized with this prestigious award," said Wendel Barr, SynteractHCR CEO. "Mary's selection as one of the PharmaVOICE 100 is a validation of her ability to mentor her staff and colleagues in a way that is substantial and measurable. She is inspirational as an excellent role model and most deserving of this industry recognition."

Honorees were announced in the July/August 2013 issue of PharmaVOICE magazine. Each year, PharmaVOICE receives thousands of nominations from readers who collectively nominate and vote for their choice of the most influential corporate leaders in their field. Candidates are chosen based on their ability to inspire their peers through their actions. The nominees must exhibit strong leadership qualities, fearless and unique approaches to problems, and innovation in strategies, products and services. Submissions are provided to PharmaVOICE by colleagues who believe their nominee meets all of the criteria necessary.

About SynteractHCR (www.synteracthcr.com)

SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular, and respiratory, among other indications.  For more information, please visit www.SynteractHCR.com or follow us at @SynteractHCR.

CONTACT:
Ryan Sabatini
ryan@clearpointagency.com
760-230-2424


'/>"/>
SOURCE SynteractHCR
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
2. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
3. Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
6. Cepheid Welcomes Senior Vice President of Human Resources
7. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
8. PinneyAssociates Announces Senior Staff Promotions
9. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
10. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 AquaBounty Technologies, Inc. (AIM: ABTU; ... in aquaculture and a majority-owned subsidiary of Intrexon Corporation ... completed the listing of its common shares on the ... Intrexon. "AquaBounty,s listing on NASDAQ represents an ... exposure to the U.S. markets as we advance plans ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... of drug and device development, and Prism Clinical Research , a leader ... announced Verified Clinical Trials (VCT) has been selected by both companies ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell , ... technology, and STMicroelectronics (NYSE: STM), a global ... electronics applications, announced today the launch of a ... biometric wearables that includes ST,s compact SensorTile ... Benchmark™ biometric sensor system. Together, SensorTile and ...
(Date:12/15/2016)... Germany , December 15, 2016 ... today announced an agreement with NuData Security, an award-winning ... The partnership will enable clients to focus on good customer ... data protection regulation. ... In order to provide a one-stop fraud prevention ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
Breaking Biology News(10 mins):